LEADER 04264nam 22006374a 450 001 9910954508703321 005 20251017110058.0 010 $a9780309169950 010 $a030916995X 010 $a9780309510257 010 $a0309510252 035 $a(CKB)111069351125330 035 $a(SSID)ssj0000111987 035 $a(PQKBManifestationID)11127874 035 $a(PQKBTitleCode)TC0000111987 035 $a(PQKBWorkID)10102381 035 $a(PQKB)11531041 035 $a(MiAaPQ)EBC3375263 035 $a(Au-PeEL)EBL3375263 035 $a(CaPaEBR)ebr10032472 035 $a(OCoLC)923255548 035 $a(Perlego)4735411 035 $a(DNLM)1142298 035 $a(BIP)53854132 035 $a(BIP)7642486 035 $a(EXLCZ)99111069351125330 100 $a20020129d2002 uy 0 101 0 $aeng 135 $aurcn||||||||| 181 $ctxt 182 $cc 183 $acr 200 00$aBiological threats and terrorism $eassessing the science and response capabilities : workshop summary /$fStacey L. Knobler, Adel A.F. Mahmoud, and Leslie A. Pray, editors 205 $a1st ed. 210 $aWashington, DC $cNational Academy Press$dc2002 215 $axvi, 317 p. $cill 300 $a"Based on a workshop of the Forum on Emerging Infections, Board on Global Health, Institute of Medicine." 311 08$a9780309082532 311 08$a0309082536 320 $aIncludes bibliographical references. 327 $aFront Matter -- Preface -- Contents -- Summary and Assessment -- 1 Introduction -- 2 Assessing Our Understanding of the Threats -- 3 Vaccines: Research, Development, Production, and Procurement Issues -- 4 The Research Agenda: Implications for Therapeutic Countermeasures to Biological Threats -- 5 Assessing the Capacity of the Public Health Infrastructure -- 6 Scientific and Policy Tools for Countering Bioterrorism -- Appendix A Biological Threats and Terrorism: How Prepared Are We? Assessing the Science and Our Response Capabilities -- Appendix B Information Resources -- Appendix C Testimony of Joshua Lederberg, Ph.D. -- Appendix D Summary of the Frist-Kennedy "Bioterrorism Preparedness Act of 2001" -- Appendix E Department Of Health And Human Services: Food and Drug Administration [Docket No. 01N-0494] -- Appendix F Veterans Affairs/Department of Defense Contingency -- Appendix G The Model State Emergency Health Powers Act -- Appendix H NACCHO Research Brief: Assessment of Local Bioterrorism and Emergency Preparedness -- Appendix I Statement on Vaccine Development -- Appendix J Testimony of Kenneth I. Shine, M.D. -- Appendix K Glossary and Acronyms -- Appendix L Forum Member, Speaker, and Staff Biographies. 330 $aIn the wake of September 11th and recent anthrax events, our nation's bioterrorism response capability has become an imminent priority for policymakers, researchers, public health officials, academia, and the private sector. In a three-day workshop, convened by the Institute of Medicine's Forum on Emerging Infections, experts from each of these communities came together to identify, clarify, and prioritize the next steps that need to be taken in order to prepare and strengthen bioterrorism response capabilities. From the discussions, it became clear that of utmost urgency is the need to cast the issue of a response in an appropriate framework in order to attract the attention of Congress and the public in order to garner sufficient and sustainable support for such initiatives. No matter how the issue is cast, numerous workshop participants agreed that there are many gaps in the public health infrastructure and countermeasure capabilities that must be prioritized and addressed in order to assure a rapid and effective response to another bioterrorist attack. 606 $aBioterrorism$vCongresses 615 0$aBioterrorism 676 $a363.3/2 701 $aKnobler$b Stacey$01804165 701 $aMahmoud$b Adel A. F$0101473 701 $aPray$b Leslie A$0880793 712 02$aInstitute of Medicine (U.S.).$bForum on Emerging Infections. 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910954508703321 996 $aBiological threats and terrorism$94367193 997 $aUNINA